German multinational drug maker Bayer AG (DE:BAYN) intends to continue its U.S. expansion plans despite facing hiccups in its drug trials, the company’s pharmaceuticals head Stefan Oelrich told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results